老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
2倍做多NVO ETF-Defiance
12.42
+0.8200
7.07%
盤後：
12.49
0.0691
+0.56%
16:51 EDT
成交量：
32.16萬
成交額：
394.13萬
市值：
3,251.68萬
市盈率：
- -
高：
12.53
開：
11.74
低：
11.74
收：
11.60
52周最高：
36.00
52周最低：
9.23
股本：
261.81萬
流通股本：
261.81萬
量比：
1.14
換手率：
12.28%
股息：
- -
股息率：
- -
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
諾和諾德（NVO）跌1.24% 叫停ziltivekimab兩項後期試驗 管線再遇挫折
金吾财讯
·
09/08
諾和諾德（NVO）司美格魯肽兒童肥胖三期試驗取得積極成果
金吾财讯
·
09/08
諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率
智通财经
·
09/07
諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率
智通财经
·
09/07
諾和諾德 Ziltivekimab 再遭挫折：兩項 III 期試驗提前終止
老虎资讯综合
·
09/07
ETF周報 | 2倍做多Robinhood ETF升逾34%；二倍做多彭博原油ETF升逾11%；三倍做多半導體ETF升逾5%；加密與油氣鏈條槓桿居前
ETF周报
·
09/06
研究發現，美國越來越多的12歲以下兒童被開具減肥藥處方
路透中文
·
09/05
ETF異動 | 加密貨幣全線飆升 南方兩倍做多MSTR(07799)升逾25% 兩倍做多Coinbase(07711)升逾14%
智通财经
·
09/04
諾和諾德(NVO)股票9月2日盤中上漲3.17%：關鍵驅動因素揭曉
TradingKey中文
·
09/02
諾和諾德在德國推出減肥藥Wegovy
路透中文
·
09/01
新版國家基藥目錄9月1日生效，司美格魯肽注射液(諾和泰®)為基層糖尿病用藥提供新選擇
智通财经网
·
09/01
Hims & Hers在澳大利亞推出GLP-1減肥藥及治療方案
格隆汇
·
09/01
1減肥藥即使在低起始劑量下也有效
路透中文
·
09/01
不止步於「減肥藥之王」 禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道
智通财经
·
08/31
不止步於「減肥藥之王」 禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道
智通财经
·
08/31
減重用司美格魯肽片上市申請獲受理 口服減重藥戰火燃至中國市場
每日经济新闻
·
08/31
印度糖尿病全球第二多，月費降至14美元，GLP-1減肥藥為何仍賣不動？
华尔街见闻
·
08/29
焦點-超越體重：男性紛紛前往美容診所，以實現減肥蜕變
路透中文
·
08/28
港股存儲芯片概念股下跌，南方兩倍做多SK海力士跌8%，南方兩倍做多三星電子跌超6%，瀾起科技跌4%，兆易創新跌近4%。
智通财经
·
08/28
從「一針瘦」到「一片減」？諾和諾德口服減重藥在華報產
格隆汇
·
08/28
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/NVOX/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"NVOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"2倍做多NVO ETF-Defiance","latestPrice":12.42,"timestamp":1789675200000,"preClose":11.6,"halted":0,"volume":321597,"hourTrading":{"tag":"盘后","latestPrice":12.4891,"preClose":12.42,"latestTime":"16:51 EDT","volume":412,"amount":5144.669956,"timestamp":1789678314279,"change":0.0691,"changeRate":0.005564,"amplitude":0.006369},"delay":0,"changeRate":0.07068965517241382,"floatShares":2618100,"shares":2618100,"eps":0,"marketStatus":"盤後交易","change":0.82,"latestTime":"09-17 17:26:32 EDT","open":11.74,"high":12.53,"low":11.74,"amount":3941259.995772,"amplitude":0.068103,"askPrice":12.55,"askSize":100,"bidPrice":12.4,"bidSize":400,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":11.6,"sharesOutstanding":4098101,"nav":12.06,"aum":31574298.06,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":11.776,"preClose":11.6,"latestTime":"09:26 EDT","volume":7827,"amount":91568.871354,"timestamp":1789651593775,"change":0.176,"changeRate":0.015172,"amplitude":0.016672},"postHourTrading":{"tag":"盘后","latestPrice":12.4891,"preClose":12.42,"latestTime":"16:51 EDT","volume":412,"amount":5144.669956,"timestamp":1789678314279,"change":0.0691,"changeRate":0.005564,"amplitude":0.006369},"volumeRatio":1.135697,"impliedVol":0.7251,"impliedVolPercentile":0.288},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","floatShares":2618100,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.135697,"shares":2618100,"dividePrice":0,"high":12.53,"amplitude":0.068103,"preClose":11.6,"low":11.74,"week52Low":9.23,"pbRate":"--","week52High":36,"institutionHeld":0,"latestPrice":12.42,"committee":0.6,"eps":0,"divideRate":0,"volume":321597,"delay":0,"ttmEps":0,"open":11.74,"prevYearClose":21.89,"prevWeekClose":12.39,"prevMonthClose":13.84,"prevQuarterClose":16.05,"fiveDayClose":12.98,"twentyDayClose":14.64,"sixtyDayClose":15.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-09","symbol":"NVOX","defaultRemindTime":1765290600000,"type":"split","dateTimestamp":1765256400000,"forFactor":8,"toFactor":1,"ratio":8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOX\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665321472","title":"諾和諾德（NVO）跌1.24% 叫停ziltivekimab兩項後期試驗 管線再遇挫折","url":"https://stock-news.laohu8.com/highlight/detail?id=2665321472","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665321472?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:04","pubTimestamp":1788861897,"startTime":"0","endTime":"0","summary":"消息面上，诺和诺德宣布，提前终止在研心脏候选药物ziltivekimab的两项后期临床试验，公司研发管线再添新的挫折。不过，针对心梗后康复患者的另一项ziltivekimab临床试验仍将继续推进，预计2027年上半年读出试验结果。ziltivekimab被诺和诺德寄予厚望，公司希望借助该药物打开心血管疾病市场，降低对肥胖、糖尿病药物的业务依赖，本次试验终止，对其心血管管线是一次重要打击。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/YzZhYTk2ZjUwYWIwODUzYmVlYzUyNzEyODcxMjIyNA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YzZhYTk2ZjUwYWIwODUzYmVlYzUyNzEyODcxMjIyNA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305804","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","OZEM","IE00BKVL7J92.USD","BK4588","LU1093756325.SGD","NVOX","LU0154236417.USD","NVOH","IE00BZ1G4Q59.USD","PPH","BK4532","BK4585","THNR","LU1093756168.USD","BK4007","NVOC","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329557","title":"諾和諾德（NVO）司美格魯肽兒童肥胖三期試驗取得積極成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329557","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329557?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:40","pubTimestamp":1788860407,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德（NVO）公布STEP Young三期临床试验数据，经过68周司美格鲁肽治疗，6岁至不足12岁受试儿童中，40.4%不再属于肥胖范畴。本次试验共纳入165名儿童，顺利达成主要终点，司美格鲁肽在降低BMI方面效果显著优于安慰剂；安慰剂组没有儿童脱离肥胖判定阈值。所有受试者均同步执行低热量饮食并增加运动。诺和诺德表示，药物安全性、耐受性与既往儿童及成人试验数据保持一致，未观察到生长、青春期发育相关的新增安全风险。完整的STEP Young试验详细结果，将于11月14-17日华盛顿举办的ObesityWeek 2026大会对外发布。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/MWZlOWI0Y2VlNGE3Yjk5M2Y5NzBkYzExODBlYTA4MTI1NDQ2NzI2NDIw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MWZlOWI0Y2VlNGE3Yjk5M2Y5NzBkYzExODBlYTA4MTI1NDQ2NzI2NDIw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305800","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOC","NVOH","OZEM","BK4599","BK4007","NVOX","THNR","LU1093756325.SGD","NVO","IE00BZ1G4Q59.USD","PPH","IE00BKVL7J92.USD","LU0154236417.USD","BK4532","BK4588","BK4585","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311633","title":"諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311633","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311633?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:15","pubTimestamp":1788783311,"startTime":"0","endTime":"0","summary":"诺和诺德在声明中指出，这项名为STEP Young的试验所纳入的全部受试者，在整个研究期间均接受了生活方式干预，包括限制热量摄入和增加体育锻炼。诺和诺德首席科学官马丁·霍尔斯特·兰格表示：“STEP Young试验的积极结果令人振奋，我们看好司美格鲁肽在帮助罹患肥胖的儿童方面的潜力——这些儿童除生活方式调整外，尚需药物治疗以更有效地管理其肥胖状况。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["THNR","CURE","FHLC","XLVI","TRUH","NVOX","PJP","PINK","FXH","NVOC","IYH","MEDI","RSPH","NVOH","BGIA","NBDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311616","title":"諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311616","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311616?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:15","pubTimestamp":1788783311,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CURE","XLVI","PINK","RSPH","FXH","IYH","BGIA","NBDS","FHLC","MEDI","THNR","TRUH","PJP","NVOC","NVOH","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152581768","title":"諾和諾德 Ziltivekimab 再遭挫折：兩項 III 期試驗提前終止","url":"https://stock-news.laohu8.com/highlight/detail?id=1152581768","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152581768?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:39","pubTimestamp":1788777588,"startTime":"0","endTime":"0","summary":"诺和诺德决定提前终止其炎症靶向候选药物 Ziltivekimab 的两项 III 期临床试验，此前公司判断该药物在这两项研究中都不太可能达到预期目标。两项研究均针对伴有心力衰竭和炎症的患者，将 Ziltivekimab 与安慰剂进行比较。诺和诺德最初设计 HERMES 试验，是为了评估 Ziltivekimab 对首次出现心力衰竭相关终点的时间所产生的影响。目前，ARTEMIS 正在评估 Ziltivekimab 在心脏病发作后的急性治疗场景中的潜力，预计将于 2027 年上半年公布数据结果。Ziltivekimab 是一种每月注射一次的皮下注射药物。","market":"us","thumbnail":"https://community-static.tradeup.com/news/6ff656056b447de7bcd836592cdd2ccf","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/6ff656056b447de7bcd836592cdd2ccf"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德 Ziltivekimab 再遭挫折：两项 III 期试验提前终止","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","NVOC","NVOX","NVO"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1120467657","title":"ETF周報 | 2倍做多Robinhood ETF升逾34%；二倍做多彭博原油ETF升逾11%；三倍做多半導體ETF升逾5%；加密與油氣鏈條槓桿居前","url":"https://stock-news.laohu8.com/highlight/detail?id=1120467657","media":"ETF周报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120467657?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 08:25","pubTimestamp":1788654356,"startTime":"0","endTime":"0","summary":"美股ETF本周涨幅Top52倍做多HOOD ETF-T-REX上涨34.01%。该产品两倍做空MicroStrategy，底层公司股价走强，杠杆机制放大本周跌幅。2倍做空MSTR ETF-T-Rex下跌29.72%。2倍做多PLTR ETF-Direxion下跌13.58%。Teucrium 2x Daily Wheat ETF下跌12.74%。巴西ETF-iShares MSCI上涨6.50%。台湾ETF-iShares MSCI上涨3.97%。三倍做多富时中国ETF-Direxion上涨3.09%。大宗商品ETF涨幅Top 5二倍做多彭博原油ETF上涨11.09%。行业指数ETF涨幅Top 5三倍做多半导体ETF-Direxion Daily上涨5.33%。二倍做多能源ETF-Direxion上涨4.49%。债券ETF涨幅Top 5First Trust Emerging Markets Local Currency Bond ETF上涨0.95%。iShares J.P. Morgan EM Local Currency Bond ETF上涨0.63%。Invesco Senio","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MST","LU2505996509.AUD","NVOH","IE0034235303.USD","LU0256863811.USD","LU0943347566.SGD","DBC","IE00BZ9MQY76.HKD","LU2168564065.EUR","LU2065171402.SGD","PLOO","LU1548497426.USD","LU2357627491.SGD","BK4550","SHNY","02840","RIOX","IMST","LU2592432038.USD","SPYM","IE00BJLML261.HKD","HOOG","LU0149725797.USD","LU0882574139.USD","LU2106854487.HKD","EMXC","JNUG","LU0942090050.USD","SIMX","SMH","BK4207","LU1861558580.USD","LEMB","LU2065170008.USD","LU1116320737.USD","YXI","GLL","FINX","LU2505996681.GBP","PLTZ","MSTZ","BK4535","LU2552382058.USD","LU2357305700.SGD","USG","LU1720051017.SGD","LU0640476718.USD","LU0320765489.SGD","LU0157215616.USD","BKLN","CHAU","LU1894683348.USD","DGZ","LU0211328371.USD","GLDY","82843","BK4023","PLTY","HOII","IAI","MCHI","BK4547","LITU","IGV","BK4534","LU2746668974.SGD","LU2456880835.USD","DBO","LU1363072403.SGD","LU0256863902.USD","LU1116320901.HKD","LU0251132253.USD","LU1032466523.USD","DRAG","FXP","HOYY","EDC","IAUM","FDN","KBWB","LU0683600562.USD","GDXD","BK7062","LU0211327993.USD","OILK","82823","GDXJ","GLDM","XLF","LU2265009873.SGD","LU2430703251.USD","PLTD","EWZ","BK4588","JPO","02823","FTXN","SG9999002224.SGD","LITZ","LU0265550359.USD","LU0320765646.SGD","LU0215105999.USD","EWT","LU0187121727.USD","HODU","VRC","LU2756315318.SGD","LU1064131342.USD","UYM","OUNZ","SPXS","IXC","OSSL","LU0868494617.USD","LU1861559042.SGD","LU1496350502.SGD","LU0820562030.AUD","LU0070302665.USD","PALL","GOAU","LU2264538146.SGD","MSTW","LU2237443895.HKD","PLTL","ALA","MSTU","ONTX","NVOC","NVTX","LU1162221912.USD","PLTI","NEBX","LITX","LU1267930490.SGD","DLLL","BK4007","LU1084165304.USD","SOXL","BK4515","SSO","NVOX","LU0496365809.HKD","LU2168564149.EUR","IGLD","PLTW","AIPI","IE000M9KFDE8.USD","IE00BYXW3230.USD","BGLD","LU1974910355.USD","LU1629891620.HKD","02822","LU0128525689.USD","RIOT","EEM","IE00BJTD4V19.USD","MSST","LU1244550494.USD","FBZ","SCO","LU1988902786.USD","IE00BBT3K403.USD","ERX.AU","LU1823568750.SGD","FEMR","MVV","ASHR","IE00BWXC8680.SGD","LU0265550946.USD","BK4614","LU2417539215.USD","IE00BKDWB100.SGD","LU0859254822.USD","IYF","BK4170","LU0208291251.USD","LU1235294995.USD","UGA","FNCL","BEGS","ROBN","USE","PLYY","LU1119994496.HKD","LU2065169927.USD","HXC","LU1551013342.USD","WNTR","LU2552382132.HKD","LU0048584097.USD","GOLY","07799","LU0310799852.SGD","02843","COWZ","EYES","VOO","IE00B1BXHZ80.USD","GDX","HOOX","LU2244417387.USD","IYG","SGDM","YGLD","IAUI","MTYY","JDST","BK4543","IE00B1XK9C88.USD","IE00BDCRKT87.USD","DBE","LU0417517546.SGD","RGTZ","QMmain","LU2746668461.USD","LABX","LU0345769128.USD","LU2462157665.USD","BTGD","IE00BLSP4452.SGD","LU0310800965.SGD","SPYH","HOOD","IE00B19Z9P08.USD","LITC","LU0787776722.HKD","LU2236285917.USD","DMAX","LU1267930227.SGD","DUG","BK4600","LU2054465674.USD","LU1670627923.USD","COMB","EDZ","GLD","IE00BK4W5M84.HKD","LU0345770993.USD","RTYY","FGDL","LU0211331839.USD","PLTU","YANG","IE00BK4W5L77.USD","LU2168564222.USD","SPY","KGLD","LU1261432733.SGD","BTC.USD.HKCC","BK4516","IE00B775SV38.USD","RGYY","RING","BK4127","LU0820561909.HKD","SPXU","SMAX","LU0006306889.USD","LU2237443465.HKD","159195","MSTK","NBIZ","CRPT","SH","MSTY","BKCH","LU1244550577.SGD","XPP","IEO","TEUP","UPRO","SOXX","LU0203347892.USD","YINN","PXE","LU2213496289.HKD","RGTX","LU0211326755.USD","IE0034235188.USD","LU2065171311.SGD","IE00BDRTCR15.USD","WTIU","IAU","LU2430703095.HKD","CWB","DUST","BK4566","LU0106831901.USD","NBIG","EEMA","IE00BJTD4N35.SGD","LU1366333091.USD","MGCmain","MSTX","LU1670628061.USD","SPXL","IE00BLSP4239.USD","SPDN","XW","LU0267386448.USD","MOO","NBIL","MIDU","GDXU","VFH","FAAR","FLCH","MSTR","LU2756315664.SGD","CEF","LU1551013425.SGD","UGL","LU0106261372.USD","WXET","LU0203345920.USD","LU2381873111.SGD","BNO","OILU","IXG","LU1894683264.USD","LU0868494708.USD","AAAU","SDS","TFNS","BK4595","LU2242649171.HKD","EEMO","FLBR","LU0820561818.USD","IE00BN8TJ469.HKD","LU1720051108.HKD","RGTU","GDXY","ASHS","LU2023250843.SGD","07399","VWO","COZX","SPYQ","LU0689472784.USD","BAR","LU1496350171.SGD","LU0976567544.SGD","LU1244550221.USD","BK4504","BK4613","IE00B19Z9Z06.USD","EDC.AU","NBIC","ICVT","SG9999002232.USD","OILD","DGP","UYG","XES","ERX","LU1280957306.USD","LU2430703178.SGD","PLTA","LU1914381329.SGD","LU2552382215.SGD","DELL","CWEB","HOOZ","LU0052756011.USD","OIH","TRUF","KORU","HOOY","DULL","BLCK","IE00BZ1G4Q59.USD","VDE","LU2237443978.SGD","SGOL","RGTC","LU2023250504.SGD","MSDD","DIG","LU2211815571.USD","LU2168564495.EUR","GUNZ","BK4570","WLDR","GLTR","BLOX","IE0034235295.USD","HOOI","MSII","BK4585","BK4539","LU2237443549.SGD","PXJ","NVTC","LU0345770308.USD","LU0345769631.USD","VRTL","LU0234570918.USD","DRIP","LU0964807845.USD","LU2237443622.USD","SMST","DRLL","LU1145028129.USD","MSTC","ETNG","UCO","GCmain","PLTR","GUSH","BPAY","IVV","SAA","CLmain","82822","IE00BHPRN162.USD","LU0211326839.USD","LU0323591593.USD","JPMO","USL","SPLTRmain","PLT","SPYU","KWEB","DZZ","YSPY","GBUG","512480","IE00B3S45H60.SGD","LU2237443382.USD","BRZU","LU1804176565.USD","USOI","FEMB","LFGY","DRV","LITG","LU0238689110.USD","OILT","HOOW","USO","DRN","XX25.UK","PTIR","PLTG","BK4581","MSTP","HIBL","LU0971096721.USD","SHLD","JPM","PHYS","EWY","MMAX","LU2168563687.JPY","LU1917777945.USD","SPUU","LU1668664300.SGD","DAPP","IBLC","LU1046421795.USD","LU0170899867.USD","LU2023250330.USD","LU0234572021.USD","FXI","SOXS","UMDD","FTXO","CQQQ","HOOC","NBCM","FXL","IE00BKVL7J92.USD","IE00B894F039.SGD","NEMD","IE00BFXG1179.USD","BK4533","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2665561483","title":"研究發現，美國越來越多的12歲以下兒童被開具減肥藥處方","url":"https://stock-news.laohu8.com/highlight/detail?id=2665561483","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665561483?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 02:45","pubTimestamp":1788547556,"startTime":"0","endTime":"0","summary":"研究发现，美国越来越多的12岁以下儿童被开具减肥药处方路透9月4日-据周五发表的一项研究显示，由于医生们正在为患有肥胖症的年轻患者寻求新的有效治疗方法，自2019年以来，美国12岁以下儿童的GLP-1减肥药处方量已增长了300多倍。该研究涵盖了350多万名8至11岁、患有肥胖症但未患糖尿病的儿童，结果显示GLP-1减肥药的处方率从2019年的0.03%上升至截至6月的9.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL4T44W18V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","LU2361044865.SGD","THNR","IE00B1XK9C88.USD","LU2168564149.EUR","LU2168564495.EUR","IE00BFSS8Q28.SGD","SG9999015952.SGD","LU0672654240.SGD","LU0943347566.SGD","LU0786609619.USD","BK4532","LU0820562030.AUD","LU2089984988.USD","LU0109391861.USD","FHLC","IE00BFTCPJ56.SGD","LU0882574139.USD","LU0354030438.USD","LU0354030511.USD","LU2552382215.SGD","BK4588","LU2462591350.SGD","LU2471134523.USD","NVOC","LU2324357040.USD","TRUH","LU1868837300.USD","LU2023250330.USD","LU0158827948.USD","LU2491050154.USD","SG9999018857.SGD","LU1712237335.SGD","LU2108987350.USD","LU0006306889.USD","LU0256863811.USD","LU1979441026.SGD","LU0889565916.HKD","OZEM","LU2089284900.SGD","SG9999014914.USD","LU0689472784.USD","ILDR","LU0320765992.SGD","IE00BK4W5L77.USD","LU1145028129.USD","LU1629891620.HKD","LU2461242641.AUD","LU0320765059.SGD","LU2112291526.USD","LU0225283273.USD","LU0345770993.USD","VHT","LU0823434583.USD","LU1983299246.USD","IE0004445239.USD","LU1868836914.USD","LU0820561909.HKD","LU2471134796.USD","LU2746668461.USD","NVOH","SGXZ57979304.SGD","LU0174119429.USD","LU2746668974.SGD","LU2111349929.HKD","LU1868836757.USD","IE00BZ1G4Q59.USD","IE0009355771.USD","LU1804176565.USD","LU2237438978.USD","IYH","LU2896262040.SGD","LU1868837136.USD","LU2750360997.AUD","LU1127390331.HKD","IE00BK4W5M84.HKD","LU2023251221.USD","LU0417517546.SGD","LU2213496289.HKD","LU2028103732.USD","IE00B4JS1V06.HKD","LU2168564222.USD","SG9999014880.SGD","LU0353189763.USD","LU2168563687.JPY","LU2211815571.USD","XLV","LU2237443622.USD","LU0114720955.EUR","CANC","LU1093756168.USD","IE00B4R5TH58.HKD","WDNA","LU2023250504.SGD","LU2552382132.HKD","LU1069344957.HKD","IE00B7KXQ091.USD","LU2106854487.HKD","LU2756315664.SGD","FTXH","IE00BJJMRY28.SGD","BK4534","IE0005OL40V9.USD","SG9999015978.USD","LU0154236417.USD","LU2361044949.HKD","TMED","LU1917777945.USD","BK4533","LU1623119135.USD","LU1023059063.AUD","SG9999017495.SGD","IE00BWXC8680.SGD","IHE","LU0061475181.USD","RXL","LU0289739699.SGD","LU2471134879.HKD","LU0256863902.USD","LU0079474960.USD","LU0353189680.USD","SG9999013999.USD","LU1551013342.USD","LU0708995401.HKD","SG9999015945.SGD","LU0266013472.USD","LU2264538146.SGD","IE00BJJMRZ35.SGD","IXJ","LU2089283258.USD","LU1035775433.USD","IE0002141913.USD","LU1280957306.USD","LU0158827781.USD","LLYX","LU0133085943.USD","LU0471298694.HKD","LU2236285917.USD","LU0106261372.USD","LU2602419157.SGD","LLY","LU0210536198.USD","LU0345770308.USD","IE00B775H168.HKD","LU0640476718.USD","LU2237443895.HKD","BK4581","LU0787776722.HKD","IE0001KFT4U8.USD","LU2750360641.GBP","SG9999018865.SGD","LU0432979614.USD","BK4516","LU0820561818.USD","LU1720051108.HKD","LU2756315318.SGD","BK4599","IE00BFSS7M15.SGD","ELIL","AGNG","SG9999014898.SGD","LU2063271972.USD","HRTS","NVO","CURE","GDOC","LU1988902786.USD","GB00BDT5M118.USD","IE00B1BXHZ80.USD","LU0238689110.USD","LU0466842654.USD","LU2168564065.EUR","LU0683600562.USD","LU1291159041.SGD","LU0823416689.USD","LU1323610961.USD","PPH","SGXZ51526630.SGD","JDOC","LU1548497426.USD","LU2552382058.USD","LU2491049909.HKD","IE00BKDWB100.SGD","LLYZ","LU1061106388.HKD","LU1093756325.SGD","LU0234572021.USD","LU2237443382.USD","SGXZ81514606.USD","IE0004445015.USD","MHIP","PJP","LU0471298777.SGD","SG9999001176.SGD","LU0203202063.USD","LU1232071149.USD","LU0316494557.USD","LU2471134952.CNY","BK4585","LU1974910355.USD","LU1989771016.USD","LU2357305700.SGD","LU1366192091.USD","IE00BJJMRX11.SGD","LU1868836591.USD","LU2456880835.USD","MEDI","LU2468319806.SGD","SGXZ99366536.SGD","IE00BKPKM429.USD","LU0096364046.USD","LU0198837287.USD","IE00BJLML261.HKD","LU0456855351.SGD","LU0964807845.USD","ELIS","IE00BJT1NW94.SGD","LU1064131342.USD","LU2237443549.SGD","LU2361045086.USD","SG9999001176.USD","LU2237443465.HKD","LU0882574055.USD","SG9999014906.USD","LU2360106947.USD","LU2462157665.USD","MEDX","SG9999015986.USD","LU1057294990.SGD","LU2491050071.SGD","LLII","LU1267930730.SGD","LU1551013425.SGD","LU2271345857.HKD","LU1814569148.SGD","IE00BKVL7J92.USD","LU0097036916.USD","LU0109394709.USD","IE00B2B36J28.USD","LU2417539215.USD","LU2265009873.SGD","SGXZ31699556.SGD","LU1691799644.USD","LU0823434740.USD","NVOX","LU0203201768.USD","LU0385154629.USD","IE00BN29S564.USD","LU0094547139.USD","LU2087625088.SGD","LU0058720904.USD","LU0323591593.USD","LU0122379950.USD","BK4007","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381849","title":"ETF異動 | 加密貨幣全線飆升 南方兩倍做多MSTR(07799)升逾25% 兩倍做多Coinbase(07711)升逾14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381849","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381849?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 13:50","pubTimestamp":1788501052,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，沃勒鸽派表态压低加息预期，带动加密货币等风险资产反弹。截至发稿，南方两倍做多MSTR涨25.55%，报4.216港元；南方两倍做多Coinbase涨14.5%，报27.96港元。受此影响，市场对美联储加息的担忧有所缓解，带动美债收益率走低，并引发比特币、以太坊等加密货币集体大涨，比特币一度突破8.1万美元。隔夜美股加密货币概念股也大幅飙升，Strategy涨超17%，Coinbase涨超10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BLOX","07711","EZBC","BITQ","HECO","OSSL","NCIQ","BLOK","SAA","BITO","LFGY","NVOX","DEFI","FINX","CRPT","NVTC","SIMX","STCE","XW","MVV","CRY","COIN","ETTY","TEUP","07799","COZX","DIME","BITU","BITW","TEKX","SPYQ","BTCW","GDLC","TXXH","LITC","BKCH","BITB","DAPP","RGTC","GBTC","ONTX","SPUU","FDN","NBIC","BITX","FBTC","ALA","ARKB","ETNG","VRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664781705","title":"諾和諾德(NVO)股票9月2日盤中上漲3.17%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2664781705","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664781705?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 22:16","pubTimestamp":1788358576,"startTime":"0","endTime":"0","summary":"• 诺和诺德在德国和大中华区推出了其口服减重疗法。\n• 该公司继续执行其数十亿美元的股票回购计划，以回报股东。\n• 全年营收达 467.00 亿美元，净利润总计 154.80 亿美元。","market":"sg","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262146675-market-movers-nvo-20260902","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4599","LU1093756325.SGD","NVOC","LU1093756168.USD","BK4007","NVOH","THNR","NVO","BK4532","NVOX","IE00BKVL7J92.USD","OZEM","LU0154236417.USD","IE00BZ1G4Q59.USD","PPH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664832964","title":"諾和諾德在德國推出減肥藥Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664832964","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664832964?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 16:54","pubTimestamp":1788252883,"startTime":"0","endTime":"0","summary":"诺和诺德在德国推出减肥药Wegovy路透哥本哈根9月1日-丹麦制药公司诺和诺德的一位发言人周二表示，该公司已在德国推出其Wegovy口服减肥药。德国作为欧洲创新药的关键上市市场，也是欧盟最大的药品市场，是诺和诺德在欧盟27个成员国中首个推出Wegovy口服药的国家。诺和诺德一位发言人告诉路透，Wegovy口服药的价格将根据剂量而有所不同，且将与Wegovy笔式注射剂的价格相当——后者目前的药店零售价在170至280欧元之间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4T44T0RE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","NVOC","NVO","NVOX","BK4007","BK4585","LU1093756168.USD","THNR","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4599","NVOH","OZEM","BK4588","BK4532","PPH","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831114","title":"新版國家基藥目錄9月1日生效，司美格魯肽注射液(諾和泰®)為基層糖尿病用藥提供新選擇","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831114","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831114?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:44","pubTimestamp":1788248640,"startTime":"0","endTime":"0","summary":"此次调整是《国家基本药物目录》自2018年以来的重要更新，创新降糖治疗药物的纳入进一步提升了其在基层医疗机构中的可及性，为基层糖尿病规范化管理提供更优选择。司美格鲁肽注射液(诺和泰)是目前唯一纳入基药的GLP-1 RA周制剂，满足糖心肾共管共治在此以前，司美格鲁肽注射液(诺和泰)已被世界卫生组织纳入《2025年版WHO基药目录》并作为优选推荐。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490296.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4599","BK4585","NVO","LU1093756168.USD","NVOX","BK4588","BK4007","THNR","OZEM","IE00BKVL7J92.USD","NVOC","IE00BZ1G4Q59.USD","LU0154236417.USD","NVOH","BK4532","PPH","JDOC","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882140","title":"Hims & Hers在澳大利亞推出GLP-1減肥藥及治療方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882140","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664882140?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 10:10","pubTimestamp":1788228656,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["NVOH","MEDI","ELIL","RSPH","OZEM","LLII","FXH","NVOC","PINK","JDOC","ELIS","CURE","XLVI","NVOX","IYH","NBDS","LLYX","FHLC","TRUH","PJP","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664588577","title":"1減肥藥即使在低起始劑量下也有效","url":"https://stock-news.laohu8.com/highlight/detail?id=2664588577","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664588577?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 06:24","pubTimestamp":1788215063,"startTime":"0","endTime":"0","summary":"GLP-1减肥药即使在低起始剂量下也有效GLP-1类药物未必总是需要按全剂量服用患者即使使用最低剂量也能减重，但减重幅度较小低剂量GLP-1治疗并不能预防副作用Nancy Lapid路透8月31日-一项新研究表明，服用热门GLP-1减肥药且一直维持低起始剂量的患者虽然能减掉一些体重，但仍可能出现副作用，不过与逐渐增加剂量至制造商推荐较高剂量的患者相比，他们的恶心症状要轻得多。桑达拉拉詹指出，即使在较低剂量下，司美格鲁肽的肾脏结局也更佳。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4S44S1TV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU0640476718.USD","CURE","LU2552382132.HKD","LU2168564149.EUR","LU1323610961.USD","ELIL","LU2750360641.GBP","SG9999018857.SGD","SGXZ51526630.SGD","LU0345770993.USD","LU2023251221.USD","LU2237443622.USD","LU0203202063.USD","FTXH","IE00BFSS7M15.SGD","LU0672654240.SGD","LU2456880835.USD","SG9999018865.SGD","IE0002141913.USD","SG9999001176.USD","LU1868836757.USD","LU0158827948.USD","FHLC","BK4516","LU0210536198.USD","LU0417517546.SGD","LU0432979614.USD","LU2491050154.USD","LU2552382058.USD","IE00B4R5TH58.HKD","LU1127390331.HKD","LU0109394709.USD","NVOX","LU2087625088.SGD","LU2089284900.SGD","LU0198837287.USD","LU2361045086.USD","LU0133085943.USD","SGXZ81514606.USD","IE00BWXC8680.SGD","LU1868836914.USD","LU2357305700.SGD","LU0096364046.USD","LU0058720904.USD","IE00B4JS1V06.HKD","IE00BKDWB100.SGD","RXL","LU0354030511.USD","IHE","LU0256863902.USD","LU0689472784.USD","LU1623119135.USD","LU2746668461.USD","LU2756315318.SGD","IE00B1XK9C88.USD","LU0471298694.HKD","IE0004445239.USD","LU0006306889.USD","IE00BKPKM429.USD","LU0266013472.USD","VHT","MEDX","IXJ","SGXZ57979304.SGD","SG9999017495.SGD","LU0882574055.USD","LU0823434740.USD","LU2360106947.USD","SG9999015986.USD","NVO","LU1629891620.HKD","LU0256863811.USD","LU2461242641.AUD","LU2089283258.USD","LU1983299246.USD","GDOC","LU2468319806.SGD","IE00BJJMRX11.SGD","AGNG","SGXZ99366536.SGD","IE00BFSS8Q28.SGD","LU2756315664.SGD","LU0061475181.USD","SG9999015978.USD","IE0001KFT4U8.USD","LU1548497426.USD","LU2265009873.SGD","BK4534","LU1868836591.USD","MEDI","LU2168564065.EUR","LU1232071149.USD","LU1988902786.USD","LU2361044865.SGD","LU1868837300.USD","LU0320765992.SGD","LU2750360997.AUD","BK4532","LU2896262040.SGD","IE00BJT1NW94.SGD","IE00BJLML261.HKD","LU0097036916.USD","LU2237443382.USD","LU0234572021.USD","LU2552382215.SGD","LU2237438978.USD","OZEM","IE0005OL40V9.USD","WDNA","LLYZ","LU1280957306.USD","LU2112291526.USD","LU2237443549.SGD","LU1551013425.SGD","LU0354030438.USD","LLY","LU2168564222.USD","LU1989771016.USD","LU0943347566.SGD","LU2462157665.USD","LU0323591593.USD","LU1366192091.USD","LU2213496289.HKD","LU2237443895.HKD","ELIS","LU2417539215.USD","LU1814569148.SGD","LU0238689110.USD","LU2462591350.SGD","LU2471134796.USD","JDOC","LU2089984988.USD","TMED","LU0964807845.USD","LU2471134879.HKD","LU0683600562.USD","HRTS","LU0820561909.HKD","IE00B1BXHZ80.USD","LU0353189680.USD","IE00BJJMRY28.SGD","LU1093756168.USD","LU1267930730.SGD","NVOC","CANC","LU0122379950.USD","PPH","LU0079474960.USD","PJP","IE00B2B36J28.USD","BK4007","LLYX","LU0320765059.SGD","BK4588","LU0385154629.USD","SG9999015945.SGD","LU2106854487.HKD","IE00BKVL7J92.USD","SG9999013999.USD","LU0787776722.HKD","BK4533","BK4581","LU0114720955.EUR","BK4599","LU2108987350.USD","LU0823434583.USD","LU2111349929.HKD","LU2168564495.EUR","LU0158827781.USD","LU0225283273.USD","LU0316494557.USD","LU0456855351.SGD","IE00BN29S564.USD","LU1917777945.USD","LU0786609619.USD","IE00BK4W5L77.USD","LU1551013342.USD","SG9999001176.SGD","LU0174119429.USD","LU1064131342.USD","LU1720051017.SGD","IE00B7KXQ091.USD","LU0094547139.USD","BK4585","LU1291159041.SGD","LU2264538146.SGD","LU1023059063.AUD","LU0466842654.USD","SG9999014906.USD","LU1979441026.SGD","TRUH","LU2491050071.SGD","LU1712237335.SGD","LU2324357040.USD","IE00BFTCPJ56.SGD","SGXZ31699556.SGD","LU1035775433.USD","IYH","IE00BK4W5M84.HKD","LU2271345857.HKD","SG9999014914.USD","XLV","LU0823416689.USD","LU2236285917.USD","LU2602419157.SGD","LU1974910355.USD","LU0353189763.USD","LU1145028129.USD","SG9999014880.SGD","LU2211815571.USD","IE0004445015.USD","SG9999015952.SGD","LU2746668974.SGD","GB00BDT5M118.USD","LU0345770308.USD","LU0882574139.USD","LU0889565916.HKD","LU2063271972.USD","LU0820561818.USD","LU2471134523.USD","LU0154236417.USD","MHIP","IE00BJJMRZ35.SGD","LLII","LU0820562030.AUD","LU2028103732.USD","LU1061106388.HKD","LU2491049909.HKD","THNR","ILDR","LU1720051108.HKD","SG9999014898.SGD","LU2361044949.HKD","LU1804176565.USD","LU0289739699.SGD","LU1093756325.SGD","LU0471298777.SGD","LU2237443978.SGD","LU2237443465.HKD","LU1691799644.USD","LU1057294990.SGD","LU1868837136.USD","IE00B775H168.HKD","LU0109391861.USD","LU0708995401.HKD","LU2471134952.CNY","LU2168563687.JPY","LU0203201768.USD","LU0106261372.USD","LU2023250330.USD","LU2023250504.SGD","NVOH","IE00BZ1G4Q59.USD","LU1069344957.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006809","title":"不止步於「減肥藥之王」 禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006809","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663006809?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 21:12","pubTimestamp":1788181963,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来计划以高达28.8亿美元的现金收购Merida Biosciences Inc.，加码自身免疫与过敏疾病领域，以摆脱对减重和糖尿病两大支柱业务的过度依赖——正是这两大市场助其登顶全球药企市值之巅。今年以来，礼来掀起并购狂潮，迄今已宣布的交易总额超过200亿美元。5月，礼来还达成协议，以最高38亿美元收购三家疫苗研发企业。截至发稿，礼来盘前跌0.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["THNR","CURE","FHLC","XLVI","TRUH","NVOX","PJP","PINK","FXH","NVOC","IYH","MEDI","RSPH","NVOH","NBDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006800","title":"不止步於「減肥藥之王」 禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006800","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663006800?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 21:12","pubTimestamp":1788181963,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FHLC","PINK","TRUH","NVOX","MEDI","NVOH","XLVI","FXH","NBDS","RSPH","THNR","PJP","NVOC","CURE","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663553005","title":"減重用司美格魯肽片上市申請獲受理 口服減重藥戰火燃至中國市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2663553005","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663553005?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 20:52","pubTimestamp":1788180758,"startTime":"0","endTime":"0","summary":"口服减重药物的“战火”正蔓延至中国市场。据诺和诺德方面消息，8月27日，公司递交的诺和盈片剂（司美格鲁肽片）用于长期体重管理的上市申请，已正式获得受理。在此之前，这款药物已经在美国市场展现出其商业潜力——自2026年1月上市以来，累计处方量迅速突破500万张，仅上半年即贡献销售额8.55亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860303596.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860303596.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0689472784.USD","LU0823416689.USD","SG9999014906.USD","LU2168564149.EUR","LU2602419157.SGD","XLV","IE0004445239.USD","LU2168563687.JPY","SG9999017495.SGD","LU1720051017.SGD","LU2168564222.USD","LU1061106388.HKD","LU2237443465.HKD","LU2471134796.USD","SG9999013999.USD","LU1127390331.HKD","SG9999014880.SGD","ELIL","LU0471298777.SGD","IE0001KFT4U8.USD","LU1035775433.USD","LU1232071149.USD","LU2087625088.SGD","LU1979441026.SGD","LU0096364046.USD","LU0456855351.SGD","IE00BFSS7M15.SGD","LU0256863902.USD","LU2106854487.HKD","LU1868836757.USD","IE00B775H168.HKD","LU0097036916.USD","SG9999018865.SGD","LU2028103732.USD","LU1974910355.USD","SGXZ51526630.SGD","IE00BJJMRX11.SGD","IE0002141913.USD","LU2063271972.USD","LU0471298694.HKD","LU0106261372.USD","LU0203201768.USD","MHIP","SG9999018857.SGD","LU2271345857.HKD","LU2237443382.USD","IE00BKPKM429.USD","LU2089283258.USD","IE00B2B36J28.USD","SGXZ99366536.SGD","LU0234572021.USD","LU1551013425.SGD","LU1868837300.USD","LLY","RXL","IE00BZ1G4Q59.USD","PPH","LU0964807845.USD","IE00BWXC8680.SGD","LU2750360641.GBP","LU1093756168.USD","LU2236285917.USD","SG9999015978.USD","LU2896262040.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2357305700.SGD","IE00BKVL7J92.USD","ILDR","IHE","LU0823434583.USD","LU1804176565.USD","LU2237438978.USD","LU1623119135.USD","LU0345770993.USD","LU0109391861.USD","LU2360106947.USD","LU1989771016.USD","LU1868837136.USD","LU2237443622.USD","LU0640476718.USD","LU1069344957.HKD","LU1280957306.USD","IE00BJJMRY28.SGD","LU0320765992.SGD","LU0320765059.SGD","SG9999015952.SGD","LU1814569148.SGD","LU2361044865.SGD","LU2750360997.AUD","LU0417517546.SGD","LU0174119429.USD","LU0122379950.USD","TRUH","LU0820562030.AUD","IE00B1XK9C88.USD","LU0882574055.USD","CANC","LU0198837287.USD","LU2168564495.EUR","LU0154236417.USD","LU0238689110.USD","LU2456880835.USD","LU2461242641.AUD","SG9999015945.SGD","LU1323610961.USD","LU1023059063.AUD","BK4581","LU2023251221.USD","GB00BDT5M118.USD","TMED","LU0683600562.USD","GDOC","IE00BJJMRZ35.SGD","CURE","LU2211815571.USD","NVO","LU2552382058.USD","LU2213496289.HKD","LU1064131342.USD","LU0323591593.USD","IXJ","LU0203202063.USD","LU1548497426.USD","LU1291159041.SGD","LU2462157665.USD","LU0079474960.USD","LU2756315664.SGD","IE00BJLML261.HKD","LU1868836914.USD","IE0005OL40V9.USD","LU2462591350.SGD","LLYX","SG9999014898.SGD","WDNA","JDOC","IE00B7KXQ091.USD","LU0889565916.HKD","IYH","LU0820561909.HKD","LU0114720955.EUR","LU1145028129.USD","LU2264538146.SGD","SG9999015986.USD","SG9999001176.SGD","LU0158827948.USD","LU2361045086.USD","ELIS","LU0061475181.USD","NVOH","SGXZ81514606.USD","LU2746668461.USD","LU2746668974.SGD","LU0109394709.USD","LU1983299246.USD","SG9999001176.USD","IE00B1BXHZ80.USD","IE00BK4W5L77.USD","LU2168564065.EUR","LU0823434740.USD","LU1691799644.USD","LU1057294990.SGD","LU0094547139.USD","LU0289739699.SGD","BK4534","LU0672654240.SGD","LU2471134952.CNY","LU2468319806.SGD","IE00B4R5TH58.HKD","IE00BFSS8Q28.SGD","BK4532","LU1868836591.USD","LU2491050154.USD","LU0354030438.USD","LU2552382215.SGD","BK4588","LU1551013342.USD","LU0158827781.USD","SGXZ57979304.SGD","LU1720051108.HKD","LU0385154629.USD","LU2108987350.USD","LU0353189680.USD","MEDX","LU1629891620.HKD","AGNG","LU0708995401.HKD","LU2237443978.SGD","IE00B4JS1V06.HKD","BK4516","LU0466842654.USD","LU0266013472.USD","LU1712237335.SGD","LU2111349929.HKD","LU2361044949.HKD","MEDI","LU0225283273.USD","VHT","LU0006306889.USD","IE00BN29S564.USD","LU2324357040.USD","LU0133085943.USD","LU2237443895.HKD","BK4533","IE00BKDWB100.SGD","LU0353189763.USD","LU2471134523.USD","IE0004445015.USD","LU1366192091.USD","LU0354030511.USD","LU2552382132.HKD","LU0943347566.SGD","LU1917777945.USD","SGXZ31699556.SGD","LU0786609619.USD","FHLC","LU0256863811.USD","LU1988902786.USD","LU2491050071.SGD","LU2471134879.HKD","SG9999014914.USD","LU2756315318.SGD","NVOX","HRTS","LLYZ","LU0210536198.USD","LU2089284900.SGD","LU2417539215.USD","LU2089984988.USD","PJP","BK4599","LU0820561818.USD","IE00BFTCPJ56.SGD","LLII","BK4007","LU2023250330.USD","LU2023250504.SGD","FTXH","THNR","OZEM","LU2112291526.USD","LU2237443549.SGD","LU0432979614.USD","BK4585","LU0345770308.USD","LU0316494557.USD","LU1093756325.SGD","LU1267930730.SGD","IE00BK4W5M84.HKD","NVOC","LU0058720904.USD","LU2491049909.HKD","LU0787776722.HKD","LU2265009873.SGD","LU0882574139.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663168590","title":"印度糖尿病全球第二多，月費降至14美元，GLP-1減肥藥為何仍賣不動？","url":"https://stock-news.laohu8.com/highlight/detail?id=2663168590","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663168590?lang=zh_tw&edition=fundamental","pubTime":"2026-08-29 05:55","pubTimestamp":1787954138,"startTime":"0","endTime":"0","summary":"印度减肥药市场正在给全球制药行业上一堂关于市场预期的警示课。尽管GLP-1类药物在印度已实现大规模仿制、价格降至每月14美元，销售表现却远逊于预期，揭示出价格之外更深层的文化、社会与监管障碍。截至今年7月，约三十余种仿制GLP-1药物已在印度药房上市。市场冷淡直接冲击了制药行业对印度的增长押注。印度市场本被视为GLP-1药物向美欧以外拓展的重要试验场。","market":"other","thumbnail":"https://static.tigerbbs.com/62df7fa563e423b513600a842a6669e3","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/62df7fa563e423b513600a842a6669e3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3780608","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","MNDmain","XLVI","NVOC","IYH","ELIS","LLII","FXH","NVOX","ELIL","NBDS","PINK","UUP","NVOH","TRUH","UDN","THNR","OZEM","MEDI","LLYX","CURE","RSPH","JDOC","PJP"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2662693000","title":"焦點-超越體重：男性紛紛前往美容診所，以實現減肥蜕變","url":"https://stock-news.laohu8.com/highlight/detail?id=2662693000","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662693000?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 18:01","pubTimestamp":1787911288,"startTime":"0","endTime":"0","summary":"焦点-超越体重：男性纷纷前往美容诊所，以实现减肥蜕变外科医生指出，社交媒体和不断变化的男性气概规范是男性美容需求日益增长的原因GoodRx数据显示，男性目前占减肥药使用者的28.3%医生预计，随着包括口服药在内的新型减肥药问世，需求将进一步增长Sriparna Roy路透8月28日-患者和整形外科医生表示，随着畅销减肥药帮助更多美国男性瘦身，越来越多的人正在寻求针对皮肤松弛、脱发和牙齿问题的美容治疗，以完成他们的身体蜕变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4T44P0PP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203201768.USD","LU2168564149.EUR","LU2471134879.HKD","LU0210536198.USD","LU2023250504.SGD","SG9999013999.USD","IE00BKPKM429.USD","LU1366192091.USD","LU0456855351.SGD","LU2168564495.EUR","SGXZ51526630.SGD","LU0471298777.SGD","THNR","LU1267930730.SGD","LU1548497426.USD","LU0964807845.USD","LU1868837300.USD","LU0943347566.SGD","SG9999015978.USD","BK4007","IE00BJLML261.HKD","LU0432979614.USD","SG9999014906.USD","LU0234572021.USD","NVOX","LU0158827948.USD","OZEM","LU0289739699.SGD","LU0079474960.USD","LU1720051017.SGD","IE00BN29S564.USD","LU2461242641.AUD","LLII","BK4599","SGXZ31699556.SGD","TMED","LU2471134796.USD","LU0158827781.USD","LU0672654240.SGD","IYH","SG9999018865.SGD","LU0345770993.USD","LU2357305700.SGD","LU2552382132.HKD","LU0106261372.USD","BK4532","LU2089283258.USD","SGXZ99366536.SGD","IE00B4R5TH58.HKD","CURE","ELIS","LU0320765992.SGD","IE00BZ1G4Q59.USD","LU0640476718.USD","LU1232071149.USD","LU1280957306.USD","LU2491049909.HKD","LU2456880835.USD","MHIP","SG9999015952.SGD","LU0385154629.USD","BK4516","LU1064131342.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4585","LU0256863811.USD","LU0256863902.USD","IE0004445239.USD","LU2756315664.SGD","IE00BFSS7M15.SGD","LU0823434583.USD","LU0203202063.USD","LU0122379950.USD","LU1057294990.SGD","LU0787776722.HKD","LU2417539215.USD","IE00B1XK9C88.USD","LU2746668974.SGD","LU2462157665.USD","FHLC","ELIL","LU1023059063.AUD","LU2552382058.USD","LU2750360641.GBP","LU2324357040.USD","IE00BJJMRZ35.SGD","LU0354030511.USD","LU2236285917.USD","LU0345770308.USD","LU0006306889.USD","LU0316494557.USD","LU2211815571.USD","PJP","LU0820561818.USD","IE00BJJMRX11.SGD","LU2213496289.HKD","LU2471134523.USD","SG9999001176.SGD","LU2746668461.USD","BK4533","LU1868836591.USD","SG9999017495.SGD","MEDX","LU1551013342.USD","LU0823434740.USD","SG9999014880.SGD","SGXZ81514606.USD","GB00BDT5M118.USD","LU2552382215.SGD","LU0683600562.USD","LU0109394709.USD","LU0820561909.HKD","LU1127390331.HKD","LU1551013425.SGD","LU0266013472.USD","AGNG","LU2168564065.EUR","LU0174119429.USD","LU0238689110.USD","LU2237443895.HKD","LU2360106947.USD","LU1868836757.USD","LU0353189680.USD","LU1814569148.SGD","IE00B1BXHZ80.USD","IE00BKDWB100.SGD","LU0882574139.USD","IE0004445015.USD","LU1979441026.SGD","IXJ","LU2462591350.SGD","NVOC","LU0154236417.USD","SGXZ57979304.SGD","HRTS","LU1868836914.USD","CANC","LU1093756325.SGD","IE00B7KXQ091.USD","MEDI","LU1061106388.HKD","RXL","SG9999014914.USD","LU1712237335.SGD","VHT","LU2023251221.USD","LU2089984988.USD","LU2168563687.JPY","IE00B775H168.HKD","LU2089284900.SGD","LU0109391861.USD","LU2237443549.SGD","LU0882574055.USD","LLYX","IHE","LU0094547139.USD","LU0198837287.USD","LU0823416689.USD","LU0097036916.USD","LU2168564222.USD","LU1988902786.USD","LU1291159041.SGD","IE00BFTCPJ56.SGD","LU0058720904.USD","SG9999018857.SGD","IE0002141913.USD","IE00BK4W5L77.USD","LU0096364046.USD","LU1974910355.USD","LU0133085943.USD","LU2271345857.HKD","IE00BKVL7J92.USD","LU0225283273.USD","LU2237438978.USD","SG9999014898.SGD","LU1323610961.USD","LU0320765059.SGD","WDNA","SG9999015945.SGD","LLYZ","LU0471298694.HKD","IE0001KFT4U8.USD","BK4588","IE0005OL40V9.USD","PPH","LU2361044949.HKD","LU2491050071.SGD","LU1868837136.USD","LU2264538146.SGD","LLY","IE00BJJMRY28.SGD","LU1720051108.HKD","BK4581","LU0353189763.USD","LU2237443465.HKD","FTXH","LU2237443978.SGD","XLV","LU0689472784.USD","LU1804176565.USD","LU2265009873.SGD","LU2750360997.AUD","IE00BFSS8Q28.SGD","JDOC","LU2112291526.USD","LU0354030438.USD","IE00B4JS1V06.HKD","LU0323591593.USD","LU1629891620.HKD","LU2471134952.CNY","NVOH","LU0061475181.USD","LU0466842654.USD","IE00BK4W5M84.HKD","LU1989771016.USD","LU1069344957.HKD","LU1145028129.USD","LU1093756168.USD","LU2106854487.HKD","IE0009355771.USD","LU0417517546.SGD","LU2468319806.SGD","TRUH","LU1983299246.USD","NVO","LU2023250330.USD","LU0114720955.EUR","LU0786609619.USD","LU2237443622.USD","LU2111349929.HKD","LU0820562030.AUD","LU2063271972.USD","LU1691799644.USD","LU1035775433.USD","LU2896262040.SGD","LU1623119135.USD","LU0708995401.HKD","LU2361045086.USD","IE00BWXC8680.SGD","LU2756315318.SGD","LU2087625088.SGD","LU2602419157.SGD","SG9999015986.USD","GDOC","ILDR","LU2237443382.USD","LU0889565916.HKD","LU2108987350.USD","LU2361044865.SGD","LU2491050154.USD","SG9999001176.USD","LU1917777945.USD","BK4534","LU2028103732.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662205153","title":"港股存儲芯片概念股下跌，南方兩倍做多SK海力士跌8%，南方兩倍做多三星電子跌超6%，瀾起科技跌4%，兆易創新跌近4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205153","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205153?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 14:16","pubTimestamp":1787897815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SKUU","ETNG","SK","NBIC","XW","KCAI","OSSL","HYNX","EEMO","RGTU","MULL","SMAX","MUD","HBMX","LABX","NVOH","NBIG","SKDD","SKHYV","DRMP","SKHZ","NVOX","RGTC","SH","COZX","SAA","LITC","DRAM","LITZ","ALA","VXUS","ONTX","VRC","SKHU","SPYU","SKHX","DISK","RGYY","SIMX","FTXL","TEUP","SPYH","SKHY","DRMY","MVV","EDZ","SPUU","RAM","SPYQ","NVTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662533750","title":"從「一針瘦」到「一片減」？諾和諾德口服減重藥在華報產","url":"https://stock-news.laohu8.com/highlight/detail?id=2662533750","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662533750?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 11:22","pubTimestamp":1787887325,"startTime":"0","endTime":"0","summary":"卷完注射卷口服","market":"us","thumbnail":"https://img3.gelonghui.com/d567a-67687248-304e-4d05-bb40-cb2659c8b475.jpg?guru_height=3712&guru_width=5568&guru_size=1625713","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/d567a-67687248-304e-4d05-bb40-cb2659c8b475.jpg?guru_height=3712&guru_width=5568&guru_size=1625713"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6386483","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK4588","THNR","LU0154236417.USD","NVO","BK4007","PPH","NVOC","NVOH","BK4599","BK4585","OZEM","BGIA","IE00BKVL7J92.USD","LU1093756325.SGD","NVOX","BK4532","IE00BZ1G4Q59.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}